Biofrontera Inc.
Biofrontera Inc. (BFRI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BFRI · as of Sep 30, 2025
Ownership Breakdown
13
Institutional Holders
▲ 2 vs Q2
$2.39M
Total Inst. Value
▲ $934,515 vs Q2
12.80M
Shares Outstanding
freeFloat 83.56%
2.42M
13F Shares Held
▲ 380,905 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BFRI largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ROSALIND ADVISORS, INC. pharmaceutical preparations | 1.14M | 12.20% | 12.20% | $1.12B | Nov 13, 2025 | ▲ 164.3K |
AIGH CAPITAL MANAGEMENT LLC pharmaceutical preparations | 1.05M | 11.19% | 11.19% | $1.03B | Oct 31, 2025 | ▲ 71.5K |
VANGUARD GROUP INC pharmaceutical preparations | 114.0K | 1.22% | 1.22% | $112.24M | Nov 7, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 42.6K | 45.56% | 45.56% | $41.97M | Nov 12, 2025 | ▲ 2.2K |
TWO SIGMA SECURITIES, LLC pharmaceutical preparations | 20.8K | 22.23% | 22.23% | $20.48M | Nov 14, 2025 | ▲ 20.8K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 18.7K | 20.00% | 20.00% | $18.42M | Nov 13, 2025 | NEW |
XTX TOPCO LTD pharmaceutical preparations | 18.0K | 19.25% | 19.25% | $17.73M | Nov 14, 2025 | ▲ 6.4K |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC pharmaceutical preparations | 11.4K | 12.18% | 12.18% | $11.00M | Oct 30, 2025 | NEW |
CITIGROUP INC pharmaceutical preparations | 5.8K | 6.25% | 6.25% | $5.76M | Nov 10, 2025 | NEW |
BLACKROCK, INC. pharmaceutical preparations | 4.6K | 4.94% | 4.94% | $4.55M | Nov 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
6
Increased
+265.3K shares4
New Positions
first time holders2
Decreased
−14 shares3
Sold Out
fully exitedNet shares change (top 50)
+265.3K
+265.3K / −14
Net new holders
+5
4 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BFRI insider trading · insider activity
Source: SEC Form 4
12
Buy transactions
2
Sell transactions
6.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Weber Kevin Daniel director | Mar 4, 2026 | Award | 20,000 | $0.90 | $18.0K | 20.0K | Form 4 ↗ |
Luebbert Hermann CEO & Chairman | Mar 4, 2026 | Award | 125,000 | — | — | 125.0K | Form 4 ↗ |
Luebbert Hermann CEO & Chairman | Mar 4, 2026 | Award | 125,000 | $0.90 | $112.5K | 125.0K | Form 4 ↗ |
Leffler Eugene Frederick Chief Financial Officer | Mar 4, 2026 | Award | 62,500 | — | — | 62.5K | Form 4 ↗ |
Leffler Eugene Frederick Chief Financial Officer | Mar 4, 2026 | Award | 62,500 | $0.90 | $56.3K | 62.5K | Form 4 ↗ |
Lanckriet Heikki director | Mar 4, 2026 | Award | 20,000 | $0.90 | $18.0K | 20.0K | Form 4 ↗ |
Hoffman Beth J. director | Mar 4, 2026 | Award | 20,000 | $0.90 | $18.0K | 20.0K | Form 4 ↗ |
Jones George Patrick Chief Commercial Officer | Mar 4, 2026 | Award | 50,000 | — | — | 50.0K | Form 4 ↗ |
Jones George Patrick Chief Commercial Officer | Mar 4, 2026 | Award | 50,000 | $0.90 | $45.0K | 50.0K | Form 4 ↗ |
BORER JOHN J III director | Mar 4, 2026 | Award | 20,000 | $0.90 | $18.0K | 20.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Biofrontera Inc. (BFRI) is primarily owned by institutional investors, who hold approximately 18.9% of total shares outstanding. Company insiders own approximately 16.44%, while retail and public investors account for the remaining 64.62%.
The largest institutional shareholder of Biofrontera Inc. is ROSALIND ADVISORS, INC., holding approximately 1.14 million shares — equal to 12.20% of outstanding shares — as of September 30, 2025.
A total of 13 institutional investors currently hold BFRI stock, with a combined institutional value of approximately $2,387,496 as of the most recent 13F filing period.
Frequently asked questions
BFRI ownershipBiofrontera Inc. (BFRI) is primarily owned by institutional investors, who hold approximately 18.9% of shares. The largest shareholder is ROSALIND ADVISORS, INC. with a 12.20% stake. Company insiders hold 16.44%. Data sourced from SEC Form 13F as of September 30, 2025.